Does AMIVANTAMAB Cause Thrombocytopenia? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Thrombocytopenia have been filed in association with AMIVANTAMAB (Rybrevant). This represents 4.4% of all adverse event reports for AMIVANTAMAB.
33
Reports of Thrombocytopenia with AMIVANTAMAB
4.4%
of all AMIVANTAMAB reports
4
Deaths
25
Hospitalizations
How Dangerous Is Thrombocytopenia From AMIVANTAMAB?
Of the 33 reports, 4 (12.1%) resulted in death, 25 (75.8%) required hospitalization, and 7 (21.2%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
Neutropenia (23)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which AMIVANTAMAB Alternatives Have Lower Thrombocytopenia Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL